Benjamin Hébraud
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Rheumatology top 5%
- GDF15 and Related Biomarkers
Papers in
- Hematology 19
- Multiple Myeloma Research and Treatments 19
- Oncology 10
- Cancer Treatment and Pharmacology 4
- Peptidase Inhibition and Analysis 3
- Co-authors
- Jill Corre (8 shared papers)Philippe Bourin (4 shared papers)Michel Attal (12 shared papers)Murielle Roussel (8 shared papers)Hervé Avet‐Loiseau (8 shared papers)Philippe Moreau (12 shared papers)Xavier Leleu (9 shared papers)Thierry Façon (7 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Oncology (3 papers)Frontiers in Physiology (1 paper)Clinical Kidney Journal (1 paper)Cancer Research (1 paper)
- Partner nations
- FranceSpainUnited States
In The Last Decade
Benjamin Hébraud
24 papers receiving 527 citations
Peers
Comparison fields: 5 of 50
- Hematology 209
- Rheumatology 156
- Genetics 80
- Oncology 122
- Immunology 92
Countries citing papers authored by Benjamin Hébraud
This map shows the geographic impact of Benjamin Hébraud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Hébraud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Hébraud more than expected).
Fields of papers citing papers by Benjamin Hébraud
This network shows the impact of papers produced by Benjamin Hébraud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Hébraud. The network helps show where Benjamin Hébraud may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Hébraud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 160 | |
| 2 | 2012 | 77 | |
| 3 | 2018 | 73 | |
| 4 | 2019 | 60 | |
| 5 | 2020 | 25 | |
| 6 | 2021 | 22 | |
| 7 | 2018 | 17 | |
| 8 | 2017 | 16 | |
| 9 | 2017 | 16 | |
| 10 | 2008 | 14 | |
| 11 | 2014 | 6 | |
| 12 | 2020 | 6 | |
| 13 | 2015 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2019 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2018 | 4 | |
| 18 | 2019 | 4 | |
| 19 | 2016 | 4 | |
| 20 | 2023 | 3 |
About Benjamin Hébraud
Benjamin Hébraud is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 26 papers that have together received 531 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (4 papers), Cancer Treatment and Pharmacology (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Peptidase Inhibition and Analysis (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Macrophage Migration Inhibitory Factor (2 papers). The work is most often cited by research in Hematology (209 citations), Rheumatology (156 citations), Genetics (80 citations), Oncology (122 citations) and Immunology (92 citations). Benjamin Hébraud has collaborated with scholars based in France, Spain and United States. Frequent co-authors include Jill Corre, Philippe Bourin, Michel Attal, Murielle Roussel, Hervé Avet‐Loiseau, Philippe Moreau, Xavier Leleu, Thierry Façon, Mélanie Gadelorge and Nicolas Espagnolle. Their work appears in journals such as Blood, Journal of Clinical Oncology, Frontiers in Physiology, Clinical Kidney Journal and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.